Sponsored
released by
Olon Spa
03.18.24
APIs
Getting Results
-
APIs | Breaking News | Collaborations & Alliances | Industry News
The API Innovation Center, Apertus Pharmaceuticals Form Partnership
Together will bring API production of critical generic cancer drug to U.S. soil.04.12.24
-
APIs | Breaking News | Promotions & Moves
Axplora Welcomes Martin Meeson as CEO
Meeson will bring his expertise to Axplora’s global footprint of 10 sites on 3 continents while continuing to amplify the group’s capabilities and strengths.04.11.24
-
APIs | Breaking News | Promotions & Moves
EUROAPI Reorganizes Executive Leadership
Aims to improve focus and efficiency with streamlined executive committee.04.10.24
-
APIs | Capsules | Drug Development | Formulation Development | R&D | Scale-up/Technology Transfer
Why Sofgen Pharmaceuticals?
Integrated services in development, scale up, commercial manufacturing and packaging.04.04.24
-
APIs | Breaking News | Collaborations & Alliances
Prozomix, Ginkgo Bioworks Partner to Build Out Production of Next-Gen Enzyme Plates
The partnership combines Ginkgo's AI/ML and enzyme engineering expertise with Prozomix's wealth of enzyme sequence data.04.03.24
-
APIs | Bio News | Breaking News
Olon Celebrates 10 Years of Daptomycin
Doubles its production capacity to meet global demand for the active ingredient.03.25.24
-
APIs | Supply Chain
Assurance of Global Pharma Supply
Olon’s strategy for being resilient in times of instability.
-
APIs | Breaking News | cGMP Manufacture | Industry News
Noramco Forges Strategic Alignment with Purisys and Halo Pharma
Aims to addresses critical supply chain challenges, offering comprehensive API and drug product solutions in North America.03.14.24
-
APIs | Breaking News | cGMP Manufacture | Industry News
Olon, Antheia Continue API Biomanufacturing Pact
Olon provides additional capacity to support Antheia’s continued scale up and commercialization of early products, including thebaine.03.13.24
-
APIs | Breaking News | Collaborations & Alliances
Hovione Partners with Dragonfly Technologies for Sustainable API
Gains access to DragonFly’s micellar technology for chemistry-in-water processes.03.07.24
-
APIs | cGMP Manufacture | Clinical Trial Materials | Drug Development | Drug Discovery | Facilities
Newsmakers Q&A: Almac Group
Almac Pharma Services’ president and managing director talks about CDMO industry trends and the most recent expansion at its headquarters campus.Online Exclusives Tim Wright, Editor, Contract Pharma 03.07.24
-
APIs | Breaking News | cGMP Manufacture | Industry News
CordenPharma Expands Early Clinical Peptide Manufacturing
GMP manufacturing area is designed to produce peptide APIs from gram to kilogram range for clinical phase 1 and 2 requirements.03.06.24
-
APIs | Breaking News | Collaborations & Alliances
Vistin Pharma Purchases 15% Stake in CF Pharma
Signals potential for a closer partnership in the future.03.05.24
-
APIs | Scale-up/Technology Transfer
How To Select The Ideal HPAPI Manufacturing Partner
To ensure safety during HPAPI production, manufacturers must have the knowledge to effectively use containment and design high-quality equipment.02.29.24
-
APIs | Breaking News | cGMP Manufacture
Pharmaoffer Expands Services to Combat Medicine Shortages
Introduces CDMOs, CROs, and other essential contract services.02.15.24
-
APIs | Facilities
Small Molecule API Market Trends
A Q&A with Sterling Pharma Solutions’ chief commercial officer about the current state of the small molecule market.Tim Wright, Editor, Contract Pharma 02.01.24
-
APIs | Breaking News | cGMP Manufacture | Industry News
Suanfarma Unifies Brands Under Suanfarma CDMO
New identity signifies the integration of the two manufacturing plants, Cipan and Rovereto, in the API production and distribution space.01.30.24
-
APIs | Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing
Olon Group to Add New High Potency API Suite in Ohio
Expands its capabilities to serve clients developing innovative therapies for cancer, rare diseases and other challenging therapeutic areas.01.29.24
-
APIs | Cytotoxics and High Potency Manufacturing
Trends in the Development of ADCs
Targeting tumor heterogeneity with antibody-drug conjugates and novel payloads.Louise Duffy, Chief Technical Officer, Abzena 01.25.24
-
APIs | Cytotoxics and High Potency Manufacturing
API Market Trends
Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer.Online Exclusives Grand View Research 01.25.24
